Brookline Capital Acquisition Corp.

Brookline Capital Acquisition Corp., trading under the ticker APGN and sponsored by Brookline Capital Markets, was a blank-check company that focused on the healthcare and life-sciences sector. The SPAC completed its initial public offering in 2021, targeting acquisition opportunities within the biotech and biopharma space consistent with Brookline Capital's established domain expertise in healthcare investment banking. On September 5, 2023, the company filed a Form 15-12G with the SEC, terminating its registration under Section 12(g) of the Securities Exchange Act and effectively concluding its reporting obligations as a public entity. For the complete filing history, deal timeline, and ownership data on APGN and hundreds of other SPACs, sign up for full access at SpacDesk.